plerixafor has been researched along with Epilepsy, Temporal Lobe in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, T; Mu, X; Sun, X; Xiao, T; Zhao, C; Zhao, M; Zhou, Z; Zhu, G | 1 |
1 other study(ies) available for plerixafor and Epilepsy, Temporal Lobe
| Article | Year |
|---|---|
CXCR4 antagonist AMD3100 reverses the neurogenesis promoted by enriched environment and suppresses long-term seizure activity in adult rats of temporal lobe epilepsy.
Topics: Animals; Anticonvulsants; Benzylamines; Chemokine CXCL12; Cognition Disorders; Cyclams; Disease Models, Animal; Epilepsy, Temporal Lobe; Heterocyclic Compounds; Hippocampus; Housing, Animal; Kainic Acid; Male; Neurogenesis; Neurons; Random Allocation; Rats, Wistar; Receptors, CXCR4; Seizures | 2017 |